-
Mashup Score: 6
Gilead’s CEO says he’s committed to making sure people around the world can get his firm’s new HIV prevention shot Yeztugo.
Source: www.statnews.comCategories: General Medicine NewsTweet
-
Mashup Score: 13Gilead’s CEO on the approval of a powerful new drug to prevent HIV - 12 hour(s) ago
Gilead’s CEO says he’s committed to making sure people around the world can get his firm’s new HIV prevention shot Yeztugo.
Source: www.statnews.comCategories: General Medicine NewsTweet-
Gilead’s CEO on the approval of a powerful new drug to prevent HIV Daniel O’Day says he’s committed to making sure that people around the world can get his company’s new injection https://t.co/iDXvJbkecy
-
-
Mashup Score: 6U.K. decision blocks a pair of Alzheimer’s drugs from access through its national health service - 1 day(s) ago
A U.K. health agency said the Alzheimer’s drugs Kisunla and Leqembi are not cost-effective, meaning they won’t be offered through the NHS.
Source: www.statnews.comCategories: General Medicine NewsTweet-
U.K. says Alzheimer's drugs Kisunla, Leqembi aren't cost-effective https://t.co/NFaeTCObtB
-
-
Mashup Score: 15Top gene therapy regulator forced out at FDA - 1 day(s) ago
Nicole Verdun, director of the office that reviews cell and gene therapies at the Food and Drug Administration, and her deputy Rachael Anatol have been
Source: www.statnews.comCategories: General Medicine NewsTweet-
Nicole Verdun, top gene therapy regulator, is out at FDA https://t.co/kordWh13fZ
-
-
Mashup Score: 2Following second patient death, Duchenne muscular dystrophy families deserve answers about Elevidys - 1 day(s) ago
Duchenne muscular dystrophy families are sharing stories about Elevidys complications on social media. But they aren’t getting answers from Sarepta.
Source: www.statnews.comCategories: General Medicine NewsTweet-
Following second patient death, Duchenne muscular dystrophy families deserve answers about Elevidys https://t.co/0CXj82XJXm
-
-
Mashup Score: 3Vaccine advisers to consider MMRV vaccines, 'thimerosal containing' flu shots in pared-down meeting - 1 day(s) ago
RFK Jr.’s handpicked advisers will discuss two long-approved shots at their next meeting
Source: www.statnews.comCategories: General Medicine NewsTweet-
Vaccine advisers to consider MMRV vaccines, ‘thimerosal containing’ flu shots in pared-down meeting https://t.co/ws5TXARJu0
-
-
Mashup Score: 22
A new twice-yearly shot could be a “game changer” in the fight against AIDS, but experts’ hopes have dimmed because of the current political climate.
Source: www.statnews.comCategories: General Medicine NewsTweet-
HIV protection with just two shots a year: FDA approves Gilead drug https://t.co/mhqnlqXjdk via @statnews
-
-
Mashup Score: 22
A new twice-yearly shot could be a “game changer” in the fight against AIDS, but experts’ hopes have dimmed because of the current political climate.
Source: www.statnews.comCategories: General Medicine NewsTweet-
HIV protection with just two shots a year: FDA approves Gilead drug https://t.co/mhqnlqXjdk via @statnews
-
-
Mashup Score: 3Vaccine advisers to consider MMRV vaccines, 'thimerosal containing' flu shots in pared-down meeting - 1 day(s) ago
RFK Jr.’s handpicked advisers will discuss two long-approved shots at their next meeting
Source: www.statnews.comCategories: General Medicine NewsTweet-
Vaccine advisers to consider MMRV vaccines, ‘thimerosal containing’ flu shots in pared-down meeting https://t.co/ws5TXARJu0
-
-
Mashup Score: 17Bill Gates: I lost my father to Alzheimer’s. But I’m more optimistic than ever about fighting the disease - 1 day(s) ago
Bill Gates writes: “We are on the cusp of turning the tide against dementia — which makes this an especially bad time to pull back on research.”
Source: www.statnews.comCategories: General Medicine NewsTweet-
Bill Gates: I lost my father to Alzheimer’s. But I’m more optimistic than ever about fighting the disease New advances make this an especially bad time to pull back on research https://t.co/hWq4RXwqCY
-
Gilead’s CEO on the approval of a powerful new drug to prevent HIV Daniel O’Day says he’s committed to making sure that people around the world can get his company’s new injection https://t.co/iDXvJbkecy